Vanguard Group Inc Treace Medical Concepts, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TMCI
# of Institutions
138Shares Held
39.7MCall Options Held
352KPut Options Held
269K-
Armistice Capital, LLC New York, NY6.2MShares$48.5 Million0.6% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$31.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.27MShares$25.6 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.39MShares$18.7 Million0.04% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M2.06MShares$16.1 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $434M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...